PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE
申请人:FUJIFILM Corporation
公开号:US20130171415A1
公开(公告)日:2013-07-04
Disclosed is a photosensitive resin composition comprising: (Component A) an oxime sulfonate compound represented by Formula (1); (Component B) a resin comprising a constituent unit having an acid-decomposable group that is decomposed by an acid to form a carboxyl group or a phenolic hydroxy group; and (Component C) a solvent
wherein in Formula (1) R
1
denotes an alkyl group, an aryl group, or a heteroaryl group, each R
2
independently denotes a hydrogen atom, an alkyl group, an aryl group, or a halogen atom, Ar
1
denotes an o-arylene group or an o-heteroarylene group, X denotes O or S, and n denotes 1 or 2, provided that of two or more R
2
s present in the compound, at least one denotes an alkyl group, an aryl group, or a halogen atom.
[EN] OXIME ESTER PHOTOINITIATORS<br/>[FR] PHOTO-INITIATEURS À BASE D'ESTER D'OXIME
申请人:BASF SE
公开号:WO2021175855A1
公开(公告)日:2021-09-10
Disclosed are α-oxo oxime ester compounds based on carbazole derivatives which have specific substituent groups useful as a photoinitiator, as well as photopolymerizable compositions comprising said photoinitiator and ethylenically unsaturated compounds. The photopolymerizable compositions are useful, for example, in photoresist formulations for display applications, e.g. liquid crystal display (LCD), organic light emitting diode (OLED) and touch panel.
[EN] HETEROAROMATIC AND HETEROBICYCLIC AROMATIC DERIVATIVES FOR THE TREATMENT OF FERROPTOSIS-RELATED DISORDERS<br/>[FR] DÉRIVÉS AROMATIQUES HÉTÉROBICYCLIQUES ET HÉTÉROAROMATIQUES POUR LE TRAITEMENT DE TROUBLES LIÉS À LA FERROPTOSE
申请人:COLLABORATIVE MEDICINAL DEV LLC
公开号:WO2020185738A1
公开(公告)日:2020-09-17
The present application discloses heteroaromatic and heterobicyclic aromatic derivative compounds and compositions, and methods for treating ferroptosis-related disorders and diseases in patients using the compounds and compositions as disclosed herein.
[EN] SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5<br/>[FR] INHIBITEURS SÉLECTIFS DE LA PROTÉINE ARGININE MÉTHYLTRANSFÉRASE 5
申请人:PRELUDE THERAPEUTICS INC
公开号:WO2020206299A1
公开(公告)日:2020-10-08
The disclosure is directed to methods of treatment using compounds of Formula (I).
披露的内容涉及使用式(I)化合物进行治疗的方法。
[EN] POLYCATIONIC AMPHIPHILES AND POLYMERS THEREOF AS ANTIMICROBIAL AGENTS AND METHODS USING SAME<br/>[FR] COMPOSÉS AMPHIPHILES POLYCATIONIQUES ET LEURS POLYMÈRES UTILISABLES EN TANT QU'AGENTS ANTIMICROBIENS ET LEURS PROCÉDÉS D'UTILISATION
申请人:TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
公开号:WO2016172436A1
公开(公告)日:2016-10-27
The present invention includes novel polycationic amphiphilic compounds useful as antimicrobial agents. The present invention further includes novel polymers of polycationic amphiphilic compounds useful as antimicrobial agents. The present invention further includes methods useful for removing microorganisms and/or biofilm-embedded microorganisms from a surface. The present invention further includes compositions and methods useful for preventing or reducing the growth or proliferation of microorganisms and/or biofilm-embedded microorganisms on a surface.